Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Young scientists turn to gel to ease side-effects of cancer treatment

next article
09.11.2005

 


Three young scientists in the University of York’s Department of Chemistry have developed a gel that could spare cancer patients some of the unpleasant and dangerous side-effects of radiotherapy.

PhD students Andrew Wilson and Paul Watson, together with post-doctoral research fellow Mark Godber, have developed the gel which will help doctors to target cancer tumours more efficiently.


Now, the group has secured £30,000 under the Bioscience Yorkshire Enterprise Fellowship scheme to commercialise their idea.

Their product, a formulation of various chemicals, is a gelatine whose density is comparable with human tissue and can be tailored for different applications.

"This technique should allow more rapid, accurate, and therefore safer treatment of malignant tumours"

Andrew WilsonThe density of the gel alters when subjected to radiation beams, so radiologists can use it to take the guesswork out of the intensity-modulated radiation therapy treatment of malignant cancers.

By testing the radiation beam on the gel first, radiologists can judge more accurately the precise dose needed to treat the tumour, enabling them to calibrate their machines accordingly.

Andrew Wilson said: "This technique should allow more rapid, accurate, and therefore safer treatment of malignant tumours."

A different formula of the gel can be used as a phantom in the detection of brain tumours. Working with researchers at the Centre for Magnetic Resonance Investigations, at Hull Royal Infirmary, the team has developed a technique which uses the gel to improve the accuracy of targeting tumour cells.

Magnetic Resonance Spectroscopy can be used as an imaging technique allowing the tumour to be identified accurately, because of the differing biological activity in tumour cells compared with healthy cells. A phantom is required to prove the accuracy of these measurements.

The team has already supplied samples of the gels to the Princess Royal Hospital in Hull and hope to go into commercial production soon.

David Garner | Source: alphagalileo
Further information: www.york.ac.uk
www.york.ac.uk/admin/presspr/pressreleases/cancergel.htm

next article

More articles from Life Sciences:

nachricht First reconstitution of an epidermis from human embryonic stem cells
23.11.2009 | INSERM (Institut national de la santé et de la recherche médicale)

nachricht Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome
23.11.2009 | University of Washington

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

UCSB physicists move 1 step closer to quantum computing

23.11.2009 | Physics and Astronomy

Fat around the middle increases the risk of dementia

23.11.2009 | Studies and Analyses

New discovery about the formation of new brain cells

23.11.2009 | Health and Medicine

VideoLinks

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News